跳至主要内容
临床试验/NCT05161078
NCT05161078Enrolling By Invitation不适用

Improving Continuous Renal Replacement Therapy (CCRT) Outcomes in Neonates and Infants Through Interdisciplinary Collaboration

Children's Hospital Medical Center, Cincinnati9 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2021年12月16日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
1,000
试验地点
9
主要终点
Number of CARPEDIEM filters to meet prescribed treatment length

研究概览

简要总结

To date, little knowledge exists related to the use of hemodialysis (HD) in infants and has been limited to mainly single center studies. The CARPEDIEM (CArdio-Renal PEdiatric Dialysis Emergency Machine) device, which can be used to provide hemodialysis in infants, has been launched in the United States. This study/registry is designed to obtain data on critically ill infants who require HD using the CARPEDIEM device to understand the indications for initiation, best practice in prescribing and performing treatment, expected treatment course, and outcomes of a dedicated infant continuous renal replacement therapy (CRRT) machine.

详细描述

This is a retrospective and prospective, multicenter observational quality improvement study and research registry. Infants undergoing renal replacement therapy utilizing CARPEDIEM for hemodialysis will be enrolled in the study for observation. There are two arms to this study, one for quality improvement and one for research purposes. Patients enrolled in this study have the option to participate additionally in either biospecimen collection, long term follow up after CARPEDIEM, or both. Urine specimen will be collected from fresh voids, but all blood specimen will be obtained from residual clinical specimen. Investigators hope to gain more information into use, treatment course, and outcomes from infants requiring treatment with the CARPEDIEM device.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Treated with CARPEDIEM as part of standard of care at a participating institution within the United States

排除标准

  • Parents/legally authorized representative unable or unwilling to provide consent

结局指标

主要结局

Number of CARPEDIEM filters to meet prescribed treatment length

时间窗: 24 hours

Comparing actual time of treatment of each CARPEDIEM filter to the initial prescribed length of treatment at the time of filter initiation

Rate of patient survival

时间窗: through hospital discharge, an average of less than 1 year

Percent of patients treated with the CARPEDIEM who survive to hospital discharge

Rate of renal recovery

时间窗: through hospital discharge, an average of less than 1 year

Excluding patients with End Stage Renal Disease (ESRD), percent of patients treated with the CARPEDIEM who recover baseline renal function as measured by liberation from dialysis and serum creatinine returning to within less than a 50% increase over baseline.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验